Document Detail


Prevention of eczema.
MedLine Citation:
PMID:  64855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a prospective study of the development of reaginic allergy, infants of allergic parents were either subjected to an allergen-avoidance regimen from birth for six months or managed conventionally. The group on the allergen-avoidance regimen had less eczema at six months and one year than did the control group at six months. They also had a lower mean serum-total-IgE level at six weeks.
The incidence of reaginic allergy in the general population in Britain and America is about 20%. The allergy is known to be familial, either resulting from a primary overaction of the IgE-producing mechanism or from an overstimulus of a normal immunity mechanism. It has been suggested that in early infancy, vulnerability to sensitization is a transient phenomenon. To determine this, a prospective study was conducted on the development of allergy in a group of 62 infants born to allergic parents, some following a simple allergen-avoidance regimen (breastfeeding) and the rest following a conventional management. The infants were seen at the ages of 6 weeks, 3, 6, and 12 months. Atopic eczema was classified in 4 grades according to a criteria. Prick skin tests and blood analysis for IgG, IgM, and IgA were performed. 49 infants completed the study, 23 of whom successfully followed the allergen-avoidance regimen. 19 infants fed cow's milk comprised the nonregimen group. A further 7 infants were dropped from the analysis because of dietary lapses. There was no significant difference between the mean serum IgA levels of the regimen and nonregimen groups. The regiment group had significantly less eczema at 6 months (p0.010) and at (p=0.017). Comparison of parental eczema between the 2 groups showed no significant differences. Mean serum IgE levels of infants diagnosed as having eczema were greater at all ages than those who did not have eczema, significantly so at 3 months and 1 year. This study shows that changes in environmental factors can reduce the incidence of atopic eczema in an "at-risk" group. An ongoing study is being done on the group of infants in this study for the development of other allergy, as severe asthama in childhood is often preceded by eczema in infancy.
Authors:
D J Matthew; B Taylor; A P Norman; M W Turner
Related Documents :
10664935 - Genetic and environmental influences on atopic immune response in early life.
8655425 - Comparison of landim and africander cattle in southern mozambique: ii. female fertility...
16606545 - Cow's milk protein allergy. a multi-centre study: clinical and epidemiological aspects.
10076705 - Is month of birth a risk factor for subsequent development of pollen allergy in adults?
17957155 - Effect of a milk formula containing probiotics on the fecal microbiota of asian infants...
9360505 - Pituitary-adrenal response in preterm very low birth weight infants after treatment wit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Lancet     Volume:  1     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1977 Feb 
Date Detail:
Created Date:  1977-03-31     Completed Date:  1977-03-31     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  321-4     Citation Subset:  AIM; IM; J    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allergens
Breast Feeding
Dysgammaglobulinemia / complications
Eczema / etiology,  genetics,  prevention & control*
Female
Humans
Hypersensitivity / prevention & control*
Immunoglobulin A / analysis
Immunoglobulin E / analysis
Infant
Pregnancy
Prospective Studies
Reagins
Chemical
Reg. No./Substance:
0/Allergens; 0/Immunoglobulin A; 0/Reagins; 37341-29-0/Immunoglobulin E

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extrinsic allergic alveolitis and contaminated cooling-water in a factory machine.
Next Document:  Measles-virus-specific immunoglobulin-M response in subacute sclerosing panencephalitis.